IRIS
AQUARO, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.529
EU - Europa 2.477
AS - Asia 1.977
SA - Sud America 323
Continente sconosciuto - Info sul continente non disponibili 142
AF - Africa 41
OC - Oceania 5
Totale 23.494
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.452
SG - Singapore 850
RU - Federazione Russa 503
CN - Cina 419
SE - Svezia 334
DE - Germania 314
BR - Brasile 267
IT - Italia 253
UA - Ucraina 225
HK - Hong Kong 204
IE - Irlanda 167
VN - Vietnam 167
FR - Francia 164
FI - Finlandia 132
GB - Regno Unito 131
PL - Polonia 111
BD - Bangladesh 75
JP - Giappone 56
KR - Corea 50
CA - Canada 45
IN - India 43
BE - Belgio 41
CZ - Repubblica Ceca 35
AR - Argentina 27
NL - Olanda 22
ZA - Sudafrica 21
ID - Indonesia 17
IQ - Iraq 14
TR - Turchia 14
ES - Italia 12
MY - Malesia 11
MX - Messico 10
AT - Austria 9
UZ - Uzbekistan 9
EC - Ecuador 8
JM - Giamaica 7
PK - Pakistan 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
CO - Colombia 6
LT - Lituania 6
AU - Australia 5
RO - Romania 5
CI - Costa d'Avorio 4
KE - Kenya 4
OM - Oman 4
PH - Filippine 4
EU - Europa 3
IL - Israele 3
IR - Iran 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
VE - Venezuela 3
BB - Barbados 2
CR - Costa Rica 2
EG - Egitto 2
GH - Ghana 2
GR - Grecia 2
GT - Guatemala 2
LB - Libano 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MD - Moldavia 1
MF - Saint Martin 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NO - Norvegia 1
SC - Seychelles 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 23.357
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.841
Wilmington 4.540
Houston 4.033
Ann Arbor 631
Singapore 517
Fairfield 479
Chandler 418
Ashburn 409
Dallas 288
Moscow 271
San Jose 223
Seattle 219
Jacksonville 208
Hong Kong 203
Cambridge 158
Dublin 154
Beijing 148
Council Bluffs 132
Medford 111
Santa Clara 101
Kraków 92
Helsinki 81
Dearborn 79
New York 78
The Dalles 78
Los Angeles 70
Rome 57
Lawrence 53
Ho Chi Minh City 49
Tokyo 49
Hanoi 44
Brussels 41
Buffalo 38
Mülheim 36
São Paulo 33
Boardman 31
Milan 30
Menlo Park 29
Munich 28
North Bergen 25
Brno 22
Orem 22
Zhengzhou 22
Chicago 20
Palo Alto 20
Guangzhou 19
San Diego 19
Lauterbourg 17
Warsaw 16
Columbus 15
London 15
Phoenix 14
Brooklyn 13
Chennai 13
Denver 13
Jakarta 13
Porto Alegre 13
Redwood City 13
Toronto 13
Atlanta 12
Marseille 12
Montreal 12
Olomouc 12
Kunming 11
Norwalk 11
Poplar 11
San Mateo 11
Shanghai 11
Verona 11
Amsterdam 10
Johannesburg 10
Haiphong 9
Mountain View 9
Stockholm 9
Bengaluru 8
Detroit 8
Hefei 8
Nuremberg 8
Redondo Beach 8
San Francisco 8
West Jordan 8
Dong Ket 7
Frankfurt am Main 7
Jinan 7
Nanjing 7
University Park 7
Beauvais 6
Boston 6
Kuala Lumpur 6
Lappeenranta 6
Miami 6
Washington 6
Ankara 5
Baghdad 5
Bologna 5
Changsha 5
Curitiba 5
Da Nang 5
Falls Church 5
Kingston 5
Totale 19.745
Salva come PNG Salva come JPEG
Nome #
1,2,3-TRIAZOLE-[2',5'-BIS-O-(TERT-BUTYLDIMETHYLSILYL)-BETA-D-RIBOFURANOSYL]-3'-SPIRO-5''-(4''-AMINO-1'',2''-OXATHIOL 2'',2''-DIOXIDE) (TSAO) ANALOGS - SYNTHESIS AND ANTI-HIV-1 ACTIVITY 1.113
Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev 536
Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4(+) T lymphocytes 531
Therapeutic strategies towards HIV-1 infection in macrophages 519
Comparative antiviral activity of integrase inhibitors in human monocyte-derived macrophages and lymphocytes 514
Antifungal activity of Cardiospermum halicacabum L. (Sapindaceae) against Trichophyton rubrum occurs through molecular interaction with fungal Hsp90 507
Influenza virus A (H5N1): A pandemic risk? 501
Understanding HIV compartments and reservoirs 501
Activity of the (R)-Enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems 499
Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection 496
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 491
Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: New therapeutic strategies 489
HIV-1-associated dementia during HAART therapy 484
Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines 481
Effect of maraviroc on non-R5 tropic HIV-1: Refined analysis of subjects from the phase IIb study A4001029 478
Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure 474
Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: Role of cells of monocyte-macrophage lineage 473
Telomerase activity, hTERT expression, and phosphorylation are downregulated in CD4(+) T lymphocytes infected with human immunodeficiency virus type 1 (HIV-1) 470
Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes 463
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 462
Antiviral profile of HIV inhibitors in macrophages: Implications for therapy 462
Specific mutations in HIV-1 gp41 are associated with immunological success in HIV-1-infected patients receiving enfuvirtide treatment 447
gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure 445
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 445
Novel in vivo model for the study of human immunodeficiency virus type 1 transcription inhibitors: Evaluation of new 6-desfluoroquinolone derivatives 444
Natural polymorphisms of HIV-1 subtype-C integrase coding region in a large group of ARV-naïve infected individuals 442
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 438
The contribution of peroxynitrite generation in HIV replication in human primary macrophages 438
Apoptosis and telomeres shortening related to HIV-1 induced oxidative stress in an astrocytoma cell line 435
Mechanism of anti-HIV action of masked alaninyl d4T-MP derivatives 429
Limited development and progression of resistance of HIV-1 to the nucleoside analogue reverse transcriptase inhibitor lamivudine in human primary macrophages 427
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 422
The contribution of oxidative stress in apoptosis of human-cultured astroglial cells induced by supernatants of HIV-1-infected macrophages 422
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 420
Specific VpU codon changes were significantly associated with gp120 V3 tropic signatures in HIV-1 B-subtype 420
Antiretrovirus activity of a novel class of acyclic pyrimidine nucleoside phosphonates 418
In vitro activity of inhibitors of late stages of the replication of HIV in chronically infected macrophages 418
The role of HIV infection in neurologic injury 416
Does residual virus replication during successful HAART lead to HIV-1 genetic evolution? 407
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL 402
HIV infection in macrophage: role of long-lived cells and related therapeutical strategies 400
Identification of the novel KI polyomavirus in paranasal and lung tissues 397
NeuroAIDS: virological aspects of HIV infection 392
Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells 386
CCR5/CXCR4 dual antagonism for the improvement of HIV infection therapy 361
Effects of amprenavir on HIV-1 maturation, production and infectivity following drug withdrawal in chronically-infected monocytes/macrophages 344
Different kinetics of viral replication and DNA integration in the main HIV-1 cellular reservoirs in the presence and absence of integrase inhibitors 307
Antimicrobial properties of the medicinal plant Cardiospermum halicacabum L: New evidence and future perspectives 278
A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro 269
Different patterns of HIV-1 replication in MACROPHAGES is led by co-receptor usage 239
Identification of gp120 polymorphisms in HIV-1 B subtype potentially associated with resistance to fostemsavir 214
The degree of HIV-1 amino acid variability is strictly related to different disease progression rates 193
Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages 114
Crucial Role of Central Nervous System as a Viral Anatomical Compartment for HIV-1 Infection 109
Evaluation of Natural and Vaccine-Induced Anti-SARS-CoV-2 Immunity: A Comparative Study between Different Groups of Volunteers 104
New Therapies and Strategies to Curb HIV Infections with a Focus on Macrophages and Reservoirs 96
POTENT ANTIVIRAL ACTIVITY OF NEW GENERATION HIV-1 MATURATION INHIBITORS ON HUMAN PRIMARY CELLS 82
Mechanisms underlying of antiretroviral drugs in different cellular reservoirs with a focus on macrophages 68
Inhibition of the Protease of Human Immunodeficiency Virus Blocks Replication and Infectivity of the Virus in Chronically Infected Macrophages 62
Totale 23.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022699 0 49 87 52 20 75 29 28 79 91 29 160
2022/20231.060 94 87 11 163 88 211 63 63 101 4 65 110
2023/2024434 60 142 19 9 41 55 14 17 4 12 4 57
2024/20251.436 58 288 154 97 55 144 131 107 168 81 95 58
2025/20262.940 205 162 499 254 238 130 355 337 280 230 148 102
2026/2027245 117 128 0 0 0 0 0 0 0 0 0 0
Totale 23.494